Pharmafile Logo
Pharmafocus logo
Advanced Search

Medivation

Showing 15 posts of 28 posts found.

shutterstock_138095450

CureTech reclaims rare disease drug from Pfizer for $20 million

October 2, 2017
Sales and Marketing Clal Biotechnology, CureTech, Medivation, Pfizer, pharma, pharmaceutical

CureTech, a biotech firm owned by Clal Biotechnology Industries, is set to reclaim a drug it sold more than two …

News

Pfizer acquires Medivation for $14 billion

August 22, 2016
Sales and Marketing Medivation, Pfizer, acquisition, oncology

Pfizer has sealed the deal to acquire US cancer drug company Medivation for close to $14 billion in a move …

News
merck_incweb

MSD joins Medivation race, says reports

August 18, 2016
Manufacturing and Production, Research and Development, Sales and Marketing MSD, Medivation, Merck, Pfizer, Sanofi, Xtandi, takeover

MSD, known as Merck in the US and Canada, is said to have declared its interest in buying US oncology …

News
4420456374_64a3d7e6aa

Top ten stories in the pharmaceutical industry this week

August 5, 2016
Medical Communications, Research and Development Actavis, Bioelectronics, CDF, Celgne, EMA, GSK, GlaxoSmithKline, Innovate UK, Medivation, NICE, Novartis, Roche, Sanofi, Teva, appointments, apremilast, biog, breast cancer, brexit, google, pharmaceutical industry, rheumatoid arthritis, sarilumab, top ten

It’s Friday, and we’ve seen some big developments in the industry’s headlines throughout the week, from news of Glaxo-Smith-Kilne’s new …

News
sanofi_hq_reception_close

Earnings drop at Sanofi as it looks for a quick Medivation resolution

July 29, 2016
Medical Communications, Research and Development 2016, Medivation, Q2, Sanofi, earnings

Sanofi has published its earnings results for Q2, which show a fall in sales and profits as their diabetes division …

News
logo

AstraZeneca mulling a $10-billion bid for Medivation – report

July 12, 2016
Manufacturing and Production, Sales and Marketing AstraZeneca, Celgene, Medivation, Pfizer, Xtandi, cancer drug, merger and acquisition

Anglo Swedish drug firm AstraZeneca (LSE: AZN) is considering a $10-billion takeover bid for Medivation (Nasdaq: MDVN), according to reports. …

News
stocks1

Weekly Movers: Medivation, Bind Therapeutics, Insys…

July 11, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Medivation, XBiotech, juno therapeutics, markets, stocks

Medivation (Nasdaq: MDVN) stock rose after the company announced it has entered a confidentiality agreement with a number of parties …

Feature

Sanofi signs confidentiality agreement with Medivation for due diligence access for potential deal

July 6, 2016
Research and Development, Sales and Marketing Financial, M&A, MA, Medivation, Sanofi, deal, offer

Sanofi (Euronext: SAN) confirmed it has entered a confidentiality agreement with cancer drugmaker Medivation (Nasdaq: MDVN) under which it will …

News
sanofi_hq__boetie_hall

Sanofi to add future payments onto Medivation offer, according to reports

June 23, 2016
Research and Development, Sales and Marketing Medivation, Sanofi

Sanofi (NYSE: SNY) is considering adding future payments, tied to certain targets, to its proposed $9.3 billion takeover of US …

News
sanofi_hq__boetie_hall

Sanofi looks to set date for showdown with Medivation shareholders

June 2, 2016
Sales and Marketing Medivation, Sanofi, hostile, record date, shareholders, takeover

Sanofi (NYSE: SNY) has announced that it has attempted to fix a record date with Medivation (NASDAQ: MDVN) where the …

News
sanofi_hq__boetie_hall

Sanofi makes move to remove Medivation board; Medivation hits back

May 25, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Medivation, Sanofi, removal of board, takeover

Sanofi (NYSE: SNY) has taken their proposed takeover of Medivation (NASDAQ: MDVN) up several notches, with the French company filing …

News
sanofi_hq__boetie_hall

Sanofi to replace entire Medivation board to drive sale, according to reports

May 16, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Medivation, Sanofi, replace board, takeover

Reports have emerged that Sanofi is looking to step up its efforts to take over oncology firm, Medivation, as it …

News
sanofi_pasteur_scientist

Sanofi Files Hart-Scott-Rodino notification for Medivation acquisition

May 13, 2016
Medical Communications, Sales and Marketing M&A, MA, Medivation, Sanofi, deal

French drugmaker Sanofi (Euronext: SAN) on Friday said it has filed a premerger notification with the US Department of Justice Antitrust …

News
medivation

Medivation maybe mulling sale as bidding race heats up – Reports

May 10, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Deals, M&A, MA, Medivation, Pfizer, Sanofi

Cancer drugmaker Medivation (Nasdaq: MDVN) is evaluating a potential sale following the recent string of offers from big pharma firms, …

News
tug-of-war

Focus: Medivation tug-of-war rumbles on

May 6, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, AstraZeneca, Medivation, Pfizer, Sanofi, billion dollar, competition, oncology, pipeline, promising, takeover, tug of war

Medivation (NASDAQ: MDVN) has been making all the headlines as a list of suitors’ line up, all vying to secure …

Feature
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026